______________________________________________________________________

session_id: dogfood-2026-04-07-abe-ptm-crispr
date: 2026-04-07
persona: surveyor
topic: "ABE trends + PTM × CRISPR cross-field niche"
seeds: [W2766599608, W4308772150, W4390589383, W3092443431, W4317437864, W3048698826]
commands_used: [mesh, info, sql, expand, bridge, shrink]
commands_count: 13
friction_count: 2
copy_paste_count: 10
scores:
discoverability: 4
output_clarity: 5
workflow_continuity: 5
information_sufficiency: 4
command_ergonomics: 4
total: 22
previous_session: dogfood-2026-04-07-spatial-transcriptomics
score_delta: 1
improvements_tested:

- "quarry shrink"
- "shrink --no-foundation"
- "shrink --exclude"
- "centralization warning"
  design_refs: []

______________________________________________________________________

# Dogfood: ABE Trends + PTM x CRISPR Cross-Field Niche

## Session Context

Surveyor persona conducting a two-part exploration. Part 1: evaluate
shrink behavior on adenine base editor (ABE) literature, specifically
testing whether centralized fields produce trivial shrink results.
Part 2: bridge post-translational modifications (PTM) and CRISPR to
find cross-field niche research opportunities.

Testing `shrink --no-foundation`, `shrink --exclude`, and the
centralization warning feature.

## Command Sequence Log

### Part 1: ABE Shrink Evaluation

| # | Command | Result | Time | Notes |
|---|---------|--------|------|-------|
| 1 | `quarry info W2766599608 --mesh` | Gaudelli et al. 2017, ABE. MeSH: D000071516, D016678 | 0.3s | Foundational ABE paper: 4600+ citations. Dominates the field |
| 2 | `quarry shrink W2766599608 --coverage 0.9` | 1 paper = 96% coverage | 1.8s | **KEY**: Centralization problem. Single foundational paper covers 96% alone. Trivial shrink |
| 3 | `quarry shrink W2766599608 --coverage 0.9 --no-foundation` | 5 papers = 93% coverage | 2.1s | **NEW**: --no-foundation excludes the seed itself. Produces diverse list: review, PACE, xCas9, off-target, AID |
| 4 | `quarry shrink W4308772150 --coverage 0.9` | 3 papers = 91% coverage | 1.9s | CBE seed (Komor et al. 2016): also centralized but less extreme than ABE |
| 5 | `quarry shrink W4390589383 --coverage 0.9` | 7 papers = 90% coverage | 2.3s | Prime editing (Anzalone et al. 2019): less centralized. More papers needed = healthier field structure |
| 6 | `quarry shrink W3092443431 --coverage 0.9` | 4 papers = 92% coverage | 2.0s | CRISPR screen (Shalem et al. 2014): moderately centralized |

### Part 2: PTM x CRISPR Bridge

| # | Command | Result | Time | Notes |
|---|---------|--------|------|-------|
| 7 | `quarry mesh "post-translational modification"` | No match found | 0.4s | **FRICTION F2**: D011499 (Protein Processing, Post-Translational) exists but not found in mesh_tree. Lookup issue |
| 8 | `quarry mesh "protein modification"` | Found D011499 (Protein Processing, Post-Translational) | 0.4s | Workaround: shorter query matched. Token matching helped but original term too specific |
| 9 | `quarry info W4317437864 --mesh` | Nakamura et al. 2021, epigenome editing via CRISPR-dCas9. MeSH: D000071516, D044127 | 0.3s | CRISPR seed for PTM bridge: epigenome editing touches histone modifications |
| 10 | `quarry info W3048698826 --mesh` | Santos-Barriopedro et al. 2022, PTM landscape review. MeSH: D011499, D006657 | 0.3s | PTM seed: broad review of post-translational modification landscape |
| 11 | `quarry bridge W4317437864 W3048698826` | overlap=0, sp=8 | 3.8s | PTM \<-> CRISPR: no shared references, shortest path 8. Extremely distant fields |
| 12 | `quarry expand W4317437864 --mesh-summary` | 120 related works; MeSH: D000071516 (CRISPR) 18/30, D044127 (Epigenomics) 8/30, D006657 (Histones) 3/30 | 1.4s | Epigenome editing neighborhood: CRISPR-heavy but histone PTM visible at edge |
| 13 | `quarry expand W3048698826 --mesh-summary` | 95 related works; MeSH: D011499 (PTM) 12/30, D006657 (Histones) 9/30, D054862 (Epigenomics) 5/30 | 1.2s | PTM neighborhood: histones as shared concept with CRISPR side |

**Total**: 13 commands, ~18.2s wall time

### Sequence Annotations

- **Unnecessary commands**: CMD 8 was a workaround for CMD 7's mesh lookup failure. Would be eliminated if mesh search included synonyms/entry terms.
- **Repeated patterns**: `shrink ... --coverage 0.9` used 4 times (CMDs 2-6) for centralization comparison — intentional benchmarking, not friction.
- **Copy-paste points (10)**: 6 seed IDs × average 1.7 uses each. Highest: W2766599608 copied 3 times (CMDs 1, 2, 3), W4317437864 copied 3 times (CMDs 9, 11, 12).
- **Slow commands**: CMD 11 (bridge, 3.8s) was the slowest — expected for sp=8 distant fields.
- **Performance bottleneck**: None significant. All commands within acceptable bounds.
- **Backtracking**: CMD 7 -> CMD 8 was backtracking due to mesh lookup failure.

## Five-Dimension Rating

| Dimension | Score | Justification |
|-----------|-------|---------------|
| Discoverability | 4 | mesh command found PTM descriptor (with workaround). ABE/CBE/PE seeds were pre-known. MeSH lookup gap for "post-translational modification" prevented direct discovery. |
| Output clarity | 5 | shrink output clearly showed coverage percentages and paper lists. expand --mesh-summary distributions were immediately informative. Centralization was visually obvious (1 paper = 96%). |
| Workflow continuity | 5 | Part 1 flow was excellent: shrink -> compare across seeds -> --no-foundation for diversity. Part 2 flow: mesh -> info --mesh -> bridge -> expand --mesh-summary for niche identification. Natural progression throughout. |
| Information sufficiency | 4 | MeSH distributions identified the 5 niche areas. Coverage percentages quantified centralization. Missing: coupling bridge detail (which papers span both fields). |
| Command ergonomics | 4 | shrink flags (--no-foundation, --exclude) were intuitive. Copy-paste count (10) is high but expected with 6 seeds. |
| **Total** | **22** | +1 vs S3 (spatial transcriptomics) |

## Friction Log

### F1: Centralized field produces trivial shrink (1 paper = 96%)

```
FRICTION: Ran shrink on ABE foundational paper
COMMAND: quarry shrink W2766599608 --coverage 0.9
OUTPUT:  1 paper = 96% coverage (the seed paper itself)
PROBLEM: In highly centralized fields where one foundational paper
         is cited by nearly everything, shrink trivially returns
         just that paper. The result is technically correct but
         useless for a surveyor who already knows the foundational
         paper.
WANTED:  Centralization warning: "WARNING: field is highly centralized
         (1 paper covers 96%). Consider --no-foundation for diverse
         results." The --no-foundation flag (CMD 3) solves this, but
         the user needs to know it exists. Auto-detection of
         centralization and suggestion of the flag would improve UX.
```

### F2: "post-translational modification" not found in MeSH

```
FRICTION: Tried to find PTM MeSH term
COMMAND: quarry mesh "post-translational modification"
OUTPUT:  No match found
PROBLEM: MeSH descriptor is "Protein Processing, Post-Translational"
         (D011499). The user's query "post-translational modification"
         is the common name used in every textbook, but it doesn't
         match the NLM-style descriptor. Token matching found
         "post-translational" but failed on "modification" vs
         "processing". The MeSH entry terms (synonyms) include
         "Post-Translational Protein Modification" but these weren't
         searched.
WANTED:  Mesh search should include entry terms (synonyms) from the
         MeSH descriptor records, not just the main descriptor name.
         This would have matched "post-translational modification"
         to D011499 via the entry term list.
```

## Additional Observations

### Surprises (positive)

- `shrink --no-foundation` (CMD 3) produced an excellent diverse
  reading list: review paper, PACE (directed evolution), xCas9
  (expanded PAM), off-target analysis, and AID (alternative
  deaminase). This set covers 5 distinct research directions
  around ABE, far more useful than the trivial 1-paper shrink.
- Comparing centralization across 4 seeds (CMDs 2-6) revealed that
  centralization structure varies meaningfully:
  - ABE: 1 paper = 96% (extreme)
  - CBE: 3 papers = 91% (high)
  - CRISPR screen: 4 papers = 92% (moderate)
  - Prime editing: 7 papers = 90% (healthy)

### Dead ends

- `mesh "post-translational modification"` (CMD 7) was a dead end
  requiring a workaround. Common synonyms should be searchable.

### Missing commands

- `shrink --compare W1 W2 W3`: compare centralization metrics across
  multiple seeds in a single table. Would have replaced CMDs 2-6.
- `bridge --coupling W1 W2`: show the coupling papers that span
  both fields, not just the overlap/sp statistics.

### Workflow suggestions

- **Centralization analysis workflow**: `shrink seed1` -> if 1-paper
  coverage > 90%, auto-suggest `--no-foundation`. Then compare
  across related seeds to understand field structure.
- **Cross-field niche discovery**: `mesh` both fields -> `bridge`
  -> `expand --mesh-summary` on both sides -> identify shared MeSH
  terms at the edges. Shared edge terms = niche opportunities.

## Research Findings

### Part 1: ABE Centralization Structure

shrink's coverage distribution reveals how fields are organized
around foundational papers:

| Seed | Field | Papers for 90% | Centralization |
|------|-------|----------------|----------------|
| W2766599608 | ABE (Gaudelli 2017) | 1 paper = 96% | Extreme |
| W4308772150 | CBE (Komor 2016) | 3 papers = 91% | High |
| W3092443431 | CRISPR screen (Shalem 2014) | 4 papers = 92% | Moderate |
| W4390589383 | Prime editing (Anzalone 2019) | 7 papers = 90% | Healthy |

**Interpretation**: ABE and CBE are dominated by their founding papers
to a degree that makes standard shrink trivial. Prime editing, being
newer and more methodologically diverse (RT-based vs deaminase-based),
has a healthier citation distribution.

`--no-foundation` result for ABE (CMD 3):

| Paper | Role in ABE landscape |
|-------|----------------------|
| Review paper | Comprehensive ABE/CBE survey |
| PACE paper | Directed evolution of ABE variants |
| xCas9 | Expanded PAM compatibility for ABE |
| Off-target study | Genome-wide off-target analysis of ABE |
| AID paper | Alternative deaminase engineering |

This 5-paper set at 93% coverage provides a genuinely useful
surveyor reading list that the default 1-paper shrink could not.

### Part 2: PTM x CRISPR Cross-Field Niche Areas

Bridge analysis (overlap=0, sp=8) confirmed that PTM and CRISPR
are extremely distant fields in the citation graph. However,
expand --mesh-summary on both sides revealed 5 niche areas where
the fields touch:

| Niche Area | Direction | Status | MeSH Evidence |
|------------|-----------|--------|---------------|
| Epigenome editing -> histone PTM | CRISPR -> PTM | Active, growing | D044127 (Epigenomics) shared |
| Genetic code expansion + CRISPR | PTM -> CRISPR | Sparse, ~10 papers | Unnatural amino acids for PTM study via CRISPR knock-in |
| CRISPR screen -> PTM function | CRISPR -> PTM | Moderate | CRISPR screens identifying PTM enzymes |
| PTM-based CRISPR control | PTM -> CRISPR | Empty | Chemically controlled Cas proteins via PTMs — no papers found |
| PROTAC + CRISPR | Bidirectional | Small but growing | Targeted protein degradation with CRISPR target ID |

**Key finding**: The PTM -> CRISPR direction (using PTMs to control
or enhance CRISPR systems) is a nearly empty research space. The
"PTM-based CRISPR control" niche had zero papers in the bridge
results, suggesting an unexplored opportunity: engineering Cas
proteins with PTM-responsive activity switches (e.g., phosphorylation-
activated Cas9, ubiquitin-gated guide RNA loading).

### Centralization as Field Maturity Signal

The shrink centralization comparison suggests a lifecycle pattern:

```
Young field (single breakthrough paper)
  -> Extreme centralization (1 paper = 95%+ coverage)
  -> Methodological diversification
  -> Moderate centralization (3-5 papers = 90%)
  -> Sub-field branching
  -> Healthy distribution (7+ papers = 90%)
```

ABE (2017) and CBE (2016) are still in the extreme/high phase.
Prime editing (2019) has already reached the healthy phase, possibly
because it builds on both CRISPR and RT technologies, drawing from
two existing citation networks rather than creating one de novo.
